Shared Research logo
Obtained marketing approval for Darvias Injection 135mg
Q1 FY12/22 flash update
Start of data analysis for the SP-05 Phase III study
Get in touch
4F, Sumitomo Fudosan Shiba-koen Tower, 2-11-1, Shiba-koen, Minato-ku, Tokyo 105-0011, Japan
Solasia Pharma is a biotech venture that in-licenses development and sales rights for new drugs developed in the US and Europe to commercialize them in Japan and other parts of Asia.